VioQuest Pharmaceuticals, Inc.
VOQP
$0.00
$0.000.00%
| 06/30/2008 | 03/31/2008 | 12/31/2007 | 09/30/2007 | 06/30/2007 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -29.87% | -10.98% | -1.27% | 36.36% | 16.44% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -7.08% | 19.99% | 58.42% | 120.19% | 86.11% |
| Operating Income | 7.08% | -19.99% | -58.42% | -120.19% | -86.11% |
| Income Before Tax | -46.71% | -78.39% | -104.69% | 20.05% | 38.57% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -43.41% | -74.72% | -100.16% | 20.05% | 38.57% |
| Earnings from Discontinued Operations | 114.50% | 99.91% | 91.10% | 57.75% | -3.86% |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -5.55% | -28.30% | -31.69% | 26.21% | 31.90% |
| EBIT | 7.08% | -19.99% | -58.42% | -120.19% | -86.11% |
| EBITDA | 7.11% | -19.99% | -58.44% | -125.34% | -93.08% |
| EPS Basic | 2.00% | -18.76% | -18.22% | 39.26% | 47.93% |
| Normalized Basic EPS | -14.74% | -50.34% | -65.53% | -104.48% | -36.72% |
| EPS Diluted | 2.00% | -18.76% | -18.22% | 39.26% | 47.93% |
| Normalized Diluted EPS | -14.74% | -50.34% | -65.53% | -104.48% | -36.72% |
| Average Basic Shares Outstanding | 15.47% | 8.95% | 12.47% | 17.34% | 29.73% |
| Average Diluted Shares Outstanding | 15.47% | 8.95% | 12.47% | 17.34% | 29.73% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
